Our Mission

318 Forum - Caregivers of people with dementia, often viewed as invisible second patients, face daily challenges that negatively affect their quality of life. The Center for Brain Health at LSUHS shares supports that are available for caregivers.

318 Forum - International Day of Persons with Disabilities helps to bring awareness to inclusivity and social supports for people with disabilities. LSUHS School of Medicine students recognized the need for children with disabilities to have a place for social interaction with their peers, and thus Camp Tiger was founded.

KTAL6 - Three respiratory viruses are circulating nationwide: the coronavirus, flu, and RSV. Doctors from LSU Health Shreveport say one reason could be that for the past two years, many people have not been exposed to those viruses.

Three LSU Health Shreveport second year medical students have been chosen to participate in the National Institutes of Health (NIH) All of Us Research Scholar Program: Reagan Abadie, Nicholas Jones and Tyler Tran. The program aims to address the critical need to reduce disparities in healthcare and the biomedical workforce.

KTAL6 - As drug overdose rates hit an alarming peak, those who struggle with addiction look to an opioid-based treatment called buprenorphine. LSUHS Chair of Psychiatry, Dr. James Patterson, says addiction treatment specialists say the drugs can potentially stop the opioid crisis.

KSLA12 - Dr. Arshpreet Kaur, LSUHS Assistant Professor of Endocrinology, says the drug “Ozempic, or semaglutide, was approved for diabetic treatment and then they saw it had good weight loss benefits. The FDA actually approved it last year.”

Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.

Louisiana Radio Network - After a recent report from the LSUHS Louisiana Addiction Research Center showing Shreveport’s wastewater contained double the amount of methamphetamine than anywhere else in the country, many were shocked. 

KSLA12 - Dr. Dayanand Bagdure, Associate Professor of Pediatrics at LSUHS, shares why children with risk factors like asthma, bronchitis, or heart conditions may require ICU care and what symptoms to look for that may require additional medical care.

318 Forum - Dani Zoorob, MD, Chair of Obstetrics and Gynecology at LSUHS, shares information on bladder incontinence and support for related women's health issues.

Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.

Louisiana Radio Network - After a recent report from the LSUHS Louisiana Addiction Research Center showing Shreveport’s wastewater contained double the amount of methamphetamine than anywhere else in the country, many were shocked. 

National and Local News Report: LSUHS is now enrolling participants in a Phase 3 clinical trial to compare the effectiveness of standard flu vaccine to an investigational mRNA flu vaccine until mid-December. 

LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.

Dr. Chris Kevil’s laboratory at LSUHS has discovered that a clinically approved cyclodextrin-based drug called Sugammadex can act as a hydrogen sulfide donor that restores vasoactive hydrogen. This innovation has already gone through initial in vivo testing with promising results.

“Medicine in general is considerably complex and neurosurgery is extremely complex, with cavernous malformations among the most difficult to manage,” said Dr. Caleb Stewart, neurosurgeon at LSUHS. LSUHS, LSUS, Ochsner Health, and collaborators in Australia are now leveraging big data science and artificial intelligence (AI) to solve this challenge and improve care for patients.

The LSU Health Shreveport Department of Otolaryngology/Head & Neck Surgery led by Chair Dr. Cherie-Ann Nathan has received notification of manuscript CCR-21-4290R1 being selected for publication in Clinical Cancer Research, a journal of the American Association for Cancer Research.

The Louisiana Board of Regents has supported full five-year approval for the Louisiana Addiction Research Center (LARC) and Center for Emerging Viral Threats (CEVT), with the CEVT continuing to be a designated Center of Research Excellence. The Board of Regents approval follows unanimous approval of both centers by the LSU Board of Supervisors earlier this year. Both centers were previously granted provisional approval and applied for full center approval earlier this year.

The Center of Excellence for Emerging Viral Threats’ (CEVT) Viral Genomics and Surveillance Lab has surpassed uploading its’ 15,000^th sequence to GISAID (Global Initiative on Sharing Influenza Data). The LSU Health Shreveport CEVT team has worked tirelessly since early in the COVID-19 pandemic to sequence and track variants of SAR-CoV-2, the virus that causes the COVID-19 disease.

A massive new study spotlights the toll methamphetamine use may take on heart health, suggesting men, people with kidney disease and those with high blood pressure are especially at risk. While researchers don't fully understand how meth use increases the risk for heart problems, they do know it creates a lot of stress on the body, shared Dr. Chris Kevil, LSUHS Vice Chancellor for Research.

Three LSU Health Shreveport second year medical students have been chosen to participate in the National Institutes of Health (NIH) All of Us Research Scholar Program: Reagan Abadie, Nicholas Jones and Tyler Tran. The program aims to address the critical need to reduce disparities in healthcare and the biomedical workforce.

KTAL6 - Students enrolled in the Medical Student Research Program at LSU Health Shreveport presented clinical research and basic science projects to prepare them for real-world experiences in the medical field.

The 2022 LSU Health Shreveport Historically Black Colleges and Universities (HBCU) Educational Conference is being held November 4-6 at the LSUHS campus with over 65 students representing 12 universities.

KSLA12 - Dr. Tim Gilmore, Program Director of Cardiopulmonary Science shares about career opportunities in the field of respiratory therapy that are in high demand across the country.

On Tuesday, November 1st, LSU Health Shreveport’s School of Medicine formalized a guaranteed interview agreement for Centenary students seeking admission to LSU Health Shreveport’s Doctor of Medicine (MD) program.

LSUHS received national coverage on Monday, October 24th, when Louisiana Governor John Bel Edwards toured the LSUHS Center for Medical Education and Emerging Viral Threats scheduled to open in the summer of 2023. The State of Louisiana has been a fundamental funder in this $84 million, 155,000 square foot facility.

The MSRP at the LSUHS School of Medicine, sponsored by the Dean's Office, had its largest number of participants in 2022 with over one-third of the first-year class participating. Fifty-three students will be showcasing their summer research findings at a competitive poster presentation on October 26, 2022.

KSLA12 - Hosted by LSUHS, LSU Tech and ULM, Biomedical Reseach And Industry Day (BRAID) attracted students who are interested in furthering careers in biomedical fields and to learn more about non-academic jobs in the industry.

The AHEAD Program is a 5-day summer program for Louisiana high school students interested in exploring the health career programs offered at LSU Health Shreveport – School of Allied Health Professions. Apply Now!

318 Forum - The 155,000-square-foot Center for Medical Education will be home to large classroom spaces, clinical skills labs and simulation suites – each designed to encourage collaboration, active engagement and innovative thinking. 

318 Forum - Caregivers of people with dementia, often viewed as invisible second patients, face daily challenges that negatively affect their quality of life. The Center for Brain Health at LSUHS shares supports that are available for caregivers.

318 Forum - International Day of Persons with Disabilities helps to bring awareness to inclusivity and social supports for people with disabilities. LSUHS School of Medicine students recognized the need for children with disabilities to have a place for social interaction with their peers, and thus Camp Tiger was founded.

KTAL6 - Three respiratory viruses are circulating nationwide: the coronavirus, flu, and RSV. Doctors from LSU Health Shreveport say one reason could be that for the past two years, many people have not been exposed to those viruses.

KTAL6 - As drug overdose rates hit an alarming peak, those who struggle with addiction look to an opioid-based treatment called buprenorphine. LSUHS Chair of Psychiatry, Dr. James Patterson, says addiction treatment specialists say the drugs can potentially stop the opioid crisis.

KSLA12 - Dr. Arshpreet Kaur, LSUHS Assistant Professor of Endocrinology, says the drug “Ozempic, or semaglutide, was approved for diabetic treatment and then they saw it had good weight loss benefits. The FDA actually approved it last year.”

KSLA12 - Dr. Dayanand Bagdure, Associate Professor of Pediatrics at LSUHS, shares why children with risk factors like asthma, bronchitis, or heart conditions may require ICU care and what symptoms to look for that may require additional medical care.

318 Forum - Dani Zoorob, MD, Chair of Obstetrics and Gynecology at LSUHS, shares information on bladder incontinence and support for related women's health issues.

318 Forum - Michelle Yetman, PhD, associate clinical professor of rehabilitation science at LSU Health Shreveport School of Allied Health Professions shares information on early detection and intervention for diabetes management.

Shreveport Times - "It's concerning because it's early for what we normally see for an RSV respiratory season. Our patients are coming in with very clear symptoms, clear runny noses, fever, and noisy breathing. They require a lot of respiratory support," said Dr. Wanda Thomas, Associate Professor of Pediatrics at LSUHS.

KSLA12 - “RSV is the short name for Respiratory Syncytial Virus. This is a common virus that comes around in the wintertime,” Dr. John Vanchiere, Professor of Pediatrics at LSUHS, explained. “For older adults and young children, it can be much more problematic because it causes a lot of inflammation in the airways.”

NPR Red River Radio - "This virus is getting a lot of lottery tickets if you will. And it looks like, with these new variants, these new mutations are like the jackpot," says Jeremy Kamil, an immunologist at LSUHS. 

Mercury News - The (new) variants look a lot like the virus that was the template of our new bivalent booster, so vaccination still works. “It’s not a perfect match … but it’s close,” said Jeremy Kamil, a virologist at LSUHS, who studies variant mutations. “In most cases, that’s going to keep the infection in check.”

318 Forum - Dr. John Vanchiere, professor of medicine and pediatrics, director of community testing and vaccinations and principal investigator for the Pfizer Vaccine Trial in north Louisiana at LSUHS, shares, "The CDC recommends that people ages 12 years and older receive one dose of the updated COVID-19 bivalent booster vaccine if it has been at least two months since their last vaccine dose."

Washington Examiner - The Biden administration's fall campaign to get people vaccinated with the omicron booster has been off to a slow start. Dr. John Vanchiere, director for community outreach for Center for Emerging Viral Threats at LSUHS, anticipates that more people will get the updated booster as it gets closer to Thanksgiving in preparation for traveling and visiting family.

Bloomberg - Jeremy Kamil, virologist and professor of microbiology and immunology at LSUHS, shares, "Vaccinated and previously infected people have robust and still-intact lines of defense, such as memory T-cells and B-cells. People previously infected also have additional immune cells that reside in the respiratory tract."

KSLA12 - Health officials expect a rise in the number of COVID-19 cases as the colder months set in. That’s due, in part, to the fact that people will be in more confined spaces.But Dr. John Vanchiere, infectious disease specialist at LSUHS, noted also that vaccination rates are lower.

Nature.com - Jeremy Kamil, a virologist at Louisiana State University Health Shreveport shared, “The world needs to see more collaborations like this. Speed is crucial when it comes to fighting the virus.”

NPR Red River Radio - Dr. Jeremy Kamil, LSUHS virologist, answers questions about the COVID-19 booster and when to get your flu shot.

CBC News - A recent spike in cases and hospitalizations in the U.K. have scientists bracing for potential winter waves. Dr. Jeremy Kamil, a virologist at LSUHS shares, "But the possibility that they're going to cause hospitals to be overwhelmed is what I want to dial people back on because we're not seeing any signs of that."

Bossier Press-Tribune - The FDA-authorized bivalent COVID-19 vaccines, or updated boosters, are now available at LSUHS and include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19.